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Background: Endovascular repair has emerged as a less-invasive treatment for descending thoracic aortic (DTA)
aneurysms. However, the durability of this procedure relies on the stability of proximal and distal fixation sites. This
study analyzes 3 years of computed tomography (CT) data on aortic neck morphology after endovascular DTA aneurysm
repair.
Methods: Between 1999 and 2001, 139 patients underwent successful endovascular DTA repair as part of a prospective,
multicenter clinical trial investigating the Gore TAG thoracic endoprosthesis. Contrast-enhanced, high-resolution CT
scans were obtained at 1 (baseline), 12, 24, and 36 months and submitted to an independent core laboratory for image
analysis. The aorta was carefully measured by using computerized planimetry and a standardized protocol. Neck diameter
was measured at 10-mm intervals for 2 cm above and below the aneurysm and correlated with graft migration and
endoleak.
Results: The mean proximal neck diameter increased from a baseline of 30.2  4.6 mm to 32.0  4.3 mm at 36 months
(P <.05), and the annual diameter increase was 0.8, 0.4, and 0.6 mm at 12, 24, and 36 months. The mean distal neck
diameter increased from 29.4 3.8 mm to 32.1 5.0 mm at 36 months (P<.05), and the annual diameter increase was
1.1, 0.4, and 1.2 mm at 12, 24, and 36 months. At 36 months, freedom from neck dilation of >5 mm was 87%, and
freedom from migration of >10 mm was 83%. An endoleak was present in 11 (9%) of 122 patients at baseline, 7 (7%) of
96 at 12 months, 6 (9%) of 68 at 24 months, and 1 (3%) of 33 at 36 months. Neck dilation was not associated with graft
migration or endoleak.
Conclusions: Three years after endovascular repair of DTA aneurysms, there is progressive enlargement of the proximal
and distal aortic necks. Although uncommon for patients to develop significant neck dilation, when it does occur, it is not
associated with graft migration or endoleak. Continued surveillance of aortic neck morphology after descending thoracic
aneurysm endografting is recommended. (J Vasc Surg 2006;43:26-31.)Traditional therapy for repair of descending thoracic
aortic (DTA) aneurysms mandates thoracotomy, aortic
clamping, and replacement of the involved segment with a
prosthetic graft. Despite significant improvements in surgi-
cal techniques and perioperative management (ie, distal
aortic perfusion and cerebrospinal fluid drainage), substan-
tial morbidity and mortality remain.1 As a result, endovas-
cular repair has emerged as an alternative for treatment of
these aneurysms.2-5
A recent phase II multicenter trial has demonstrated
the safety and efficacy of the thoracic aneurysm graft (TAG)
(W. L. Gore, Inc, Flagstaff, Ariz) thoracic endoprosthesis.6
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26As a result, this device has received approval by the United
States Food and Drug Administration for commercial use
in the treatment of these aneurysms. However, durability of
this procedure will rely on the stability of proximal and
distal endograft fixation sites.
Previous studies on aortic neck enlargement after en-
dovascular repair of infrarenal aortic aneurysms have found
enlargement over time of both proximal and distal aortic
necks. In theory, aortic neck expansion after endograft
repair could lead to device migration, endoleak, and rup-
ture. The natural history of both proximal and distal aortic
necks after thoracic endografting remains largely unknown.
The purpose of this study was to analyze prospectively
collected core laboratory data on aortic neck morphology
after endovascular DTA aneurysm repair from patients
enrolled in the TAG pivotal trial, and to correlate any neck
size changes with migration and endoleak.
METHODS
Between September 1999 and May 2001, 139 patients
underwent successful implantation of a TAG device as part
of a phase II prospective, nonrandomized, multicenter
clinical trial. Details of the study design, device deploy-
ment, and study results have been published previously.6 In
brief, surgical candidates with a DTA aneurysm and a
minimum of 2 cm of normal aorta proximal and distal to
the aneurysm were evaluated for study inclusion. The re-
quired proximal and distal landing zones were distal to the
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artery, respectively.
The TAG device is a flexible, composite expanded
polytetrafluoroethylene (ePTFE) graft reinforced by a self-
expanding nitinol (nickel titanium alloy) wire-frame stent
along its external surface. A 7% to 18% oversizing of the
device to aorta is recommended by themanufacturer as well
as at least a 3-cm overlap when more than one device is
used.
Core laboratory description. The core laboratory
provided an independent assessment of radiographic stud-
ies performed as part of this clinical trial, and it operated
under the supervision of the Northwestern University In-
stitutional Review Board. Between June 2001 and July
2004, individual study centers submitted films of original
computed tomography (CT) scans for 126 (91%) of 139
patients enrolled in the study. An analysis of suboptimal
scans (ie, poor copies, no contrast, etc.) was conducted for
whatever parameters that were extractable. Measurements
were made according to a pre-determined image analysis
plan and stored prospectively in a database.
Image analysis plan. Study subjects were evaluated
postoperatively with plain radiographs and contrast-
Fig 1. Composite figure illustrates the selection of aortic neck
measurement sites. On the right are representative axial images of
the thoracic aortic neck at 2 cm proximal (P2) and 2 cm distal (D2)
to the aneurysm. LSA, Left subclavian artery; CA, celiac artery,
SMA, superior mesenteric arteryenhanced, high-resolution CT scans at 1 (baseline) 12, 24and 36 months. In addition, patients with endoleaks, frac-
tures, short seal zones, or other radiographic findings were
followed more frequently at investigator discretion. Neck
morphology was analyzed at baseline (n  123), 12
months (n  96), 24 months (n  68), and 36 months (n
 33). The aorta was carefully measured by using comput-
erized planimetry and a standardized protocol.
Neck size was defined as the minor diameter of the
best-fit ellipse of the aortic neck and measured at 0 (P0,
D0), 1 (P1, D1), and 2 (P2, D2) cm proximal or distal to
the aneurysm (Fig 1). When the measurement site was
parallel to the transverse plane (ie, distal arch), the diameter
of the aorta was measured perpendicular to the line of flow
(Fig 2). Neck measurements were performed in duplicate
by independent observers.
Aortic neck dilation was defined as an increase of 5
mm at all measurement sites within the neck (ie, P0, P1,
and P2, or D0, D1, and D2). The assumption for this
definition is that loss of endograft fixation and subsequent
seal would require dilation of the entire aortic neck. For
measurements of achieved neck length, the distance from
P0 to the top of the graft (proximal neck) and the distance
from D0 to the bottom of the graft (distal neck) were
recorded. For measurements of migration, the distance
from the left subclavian artery (LSA) to the top of the
device and the distance from the celiac artery to the bottom
of the device were measured and compared with baseline.
Migration was defined as 10-mm movement of the
device compared with baseline and confirmed by a multi-
specialty adjudication panel.
Endoleak was defined as contrast enhancement outside
Fig 2. Representative axial image of a thoracic aortic aneurysm
neck in the arch. In this case, the measurement site lies parallel to
the transverse plane and therefore the diameter of the aorta is
measured perpendicular to the line of flow (LOF) in the aorta.the endograft and within the aneurysm sac on CT scan.
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using a standard software package (SPSS, Inc, Chicago, Ill).
Normal distribution of the data was tested and verified.
Continuous numerical data were presented as mean 
standard deviation and compared by using the Mann-
Whitney U test. Dichotomous measures were assessed by
using Yates-corrected Pearson 2 tests. P.05 was consid-
ered significant.
RESULTS
Aneurysm neck diameter. Mean aortic neck diame-
ters at baseline, 12, 24, and 36 months are listed in Table I.
There was a statistically significant increase in the mean
neck diameter at P1, P2, D0, D1, and D2. Overall, at 36
months the mean proximal neck diameter increased 1.8 
0.2 mm (mean interval increase of 0.8, 0.4, and 0.6 mm at
1, 2, and 3 years), and the mean distal neck diameter
increased 2.7 0.5mm (mean interval increase of 1. 1, 0.4,
and 1.2 mm at 1, 2, and 3 years). Proximal neck dilation of
5 mm occurred in two patients; one between 12 and 24
months and one between 24 and 36 months. Distal neck
dilation of 5 mm occurred in three patients, all between
24 and 36 months. Freedom from neck dilation was 100%
at 12 months, 99% at 24 months, and 87% at 36 months
(Fig 3).
Migration. Migration of the device of 10 mm oc-
curred in 10 patients; this occurred at the proximal neck in
six patients and at the distal neck in four. Freedom from
migration was 97% at 12 months, 87% at 24 months, and
83% at 36 months (Fig 4). Neither neck enlargement of 5
mm at any site nor an achieved neck length of 20 mm
were associated with graft migration (Table II). Specifically,
none of the five patients who had neck dilation (proximal or
distal) developed graft migration.
Endoleak. An endoleak was present in 11 (9%) of 122
patients at baseline, 7 (7%) of 96 at 12months, 6 (9%) of 68
at 24 months, and 1 (3%) 33 at 36 months. Three patients
developed a new endoleak during follow-up, and therefore,
a total of 14 patients had a documented endoleak at some
point during the study. By core laboratory review, one
endoleak was identified as type 1 and the others as types 2,
4, or indeterminate. There were no type 3 endoleaks.
Three patients underwent four successful endovascular
interventions for endoleak; one patient between 0 and 12
months and 24 and 36 months, one patient between 12
Table I. Neck diameter (mm) after endovascular repair of
Baseline 12 months (n  123)
P0 30.6  4.5 31.3  5.2
P1 30.1  4.7 31.1  5.2
P2 30.0  4.7 30.6  4.7
D0 29.8  4.0 31.2  4.7*
D1 29.5  3.8 30.6  4.3
D2 28.9  3.7 29.7  4.4
*P .05 vs baseline.and 24 months, and one patient between 24 and 36months. The other endoleaks either resolved spontane-
ously or did not yet have core laboratory follow-up. Neck
enlargement of 5 mm at any site and an achieved neck
length of 20 mm was not associated with endoleak (Table
III). Specifically, no endoleaks developed in the five pa-
ending thoracic aortic aneurysms
24 months (n  68) 36 months (n  33)
31.9  5.0 32.1  4.5
31.6  4.9* 32.0  4.1*
30.8  5.0 31.8  4.2*
31.7  4.9* 33.0  5.0*
30.9  4.3* 32.0  4.8*
30.0  4.4 31.2  5.2*
Fig 3. Life-table analysis depicts freedom from aortic neck dila-
tion up to 36months after endovascular descending thoracic aortic
aneurysm repair n number of patients at risk.
Fig 4. Life-table analysis depicting freedom from graft migration
up to 36 months after endovascular descending thoracic aortic
aneurysm repair (n number of patients at risk).desctients who had proximal or distal neck dilation.
2JOURNAL OF VASCULAR SURGERY
Volume 43, Number 1 Hassoun et al 29DISCUSSION
Endovascular alternatives to the standard open surgical
approach have been developed and evaluated in clinical
trials. Early reports indicate that endovascular repair is a less
invasive option with lower morbidity and mortality rates.6-9
The purpose of this study was to analyze 3 years of prospec-
tively collected core laboratory CT data on aneurysm neck
morphology and associated stent-graft migration and en-
doleak from patients treated with the TAG thoracic endo-
prosthesis. Our overall findings indicate that proximal and
distal aneurysm necks dilate slightly in a time-dependent
fashion during the first 3 years after implantation. Very few
patients develop significant neck dilation (5 mm), and
both migration of the device and endoleak are uncommon.
Migration and endoleak (correlates of inadequate graft
fixation and sealing) were not associated with neck dilation.
These data suggest that in the first 3 years after endovascu-
lar DTA aneurysm repair, both proximal and distal aneu-
rysm necks display progressive dilation without clinically
significant adverse morphologic sequelae.
Long-term success of endovascular repair of aortic an-
Table II. Aneurysm neck morphology and graft migration
Variable Migration (%)
Proximal neck
Enlargement
5 mm 2/21 (10)
Otherwise 8/71 (11)
Distal neck enlargement
5 mm 1/17 (6)
Otherwise 9/75 (12)
Proximal achieved neck
length
20 mm 6/56 (11)
20 mm 4/36 (11)
Distal achieved neck
length
20 mm 7/65 (11)
20 mm 3/27 (11)
CI, Confidence interval.
Table III. Aneurysm neck morphology and endoleak
Variable Endoleak (%)
Proximal neck enlargement
5 mm 3/21 (14)
Otherwise 4/75 (5)
Distal neck enlargement
5 mm 2/17 (12)
Otherwise 6/79 (8)
Proximal achieved neck
length
20 mm 2/59 (3)
20 mm 5/36 (14)
Distal achieved neck length
20 mm 6/69 (9)
20 mm 2/27 (7)eurysms likely depends on the stability of the device fixationsites. Enlargement of the aortic neck could lead to detach-
ment of the device from the aortic wall, endoleak with
pressurization of the aneurysm sac, subsequent aneurysm
enlargement, and rupture.
Pearce et al10 have shown that the natural history of the
nonaneurysmal thoracic aorta is to enlarge over time. In
their cross-sectional study, the authors measured aortic
diameters at multiple locations in 398 patients without
vascular disease to determine normal diameters of the tho-
racic and abdominal aortas in relationship to age, gender,
and body size. They found that aortic diameter increased
with age at all levels and was greatest in the thoracic aorta,
where it increased at a rate of 0.14mm/year. These authors
also studied 16 patients with known infrarenal abdominal
aortic aneurysms and demonstrated significant enlarge-
ments of all proximal aortic segments compared with pa-
tients without aneurysms. In addition, patients with known
aneurysmal disease have a propensity to develop subse-
quent proximal aneurysms.10-12
Coselli et al12 have reported on subsequent proximal
aortic aneurysm operations in 123 patients with prior infra-
igration (%) Odds ratio (95% CI) P
/21 (90) 0.8 (0.2-4.1) 1.0
/71 (89)
/17 (94) 0.5 (0.1-4.0) .68
/75 (88)
/56 (89) 1.0 (0.3-4.0) 1.0
/36 (89)
/65 (89) 1.0 (0.3-4.3) 1.0
/27 (89)
Endoleak (%) Odds Ratio (95% CI) P
8/21 (86) 3.0 (0.6-14.4) .18
1/75 (95)
5/17 (88) 1.8 (0.3-9.6) .62
3/79 (92)
7/59 (97) 4.6 (0.8-25.0) .10
1/36 (86)
3/69 (91) 0.8 (0.2-4.4) 1.0
5/27 (93)No m
19
63
16
66
50
32
58
24No
1
7
1
7
5
3
6renal abdominal aneurysmectomy. The new aneurysm was
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patients, and the average interval between operations was
8.2 years.
These studies suggest that subsequent aortic enlarge-
ment and aneurysm formation at the aortic neck can be
expected to occur over the long-term. Our results in the
current study have demonstrated less severe neck dilation
after endovascular repair of DTA aneurysms, but with a
much shorter follow-up. Aortic neck diameters will need to
be followed over time to ensure stability of the fixation
sites.
The natural history of both proximal and distal aneu-
rysm necks after endovascular repair of DTA aneurysms has
been studied previously by Resch et al.13 They reported on
changes in aneurysm neck morphology and stent-graft
configuration after endovascular repair of DTA aneurysms
in 23 patients treated with custom-made devices.13 During
a median follow-up of 18 months (range, 1 to 18 months),
five patients (22%) displayed significant neck dilation at the
threshold of 3 mm, and this correlated with subsequent
stent-graft migration of 5 mm. This study raised impor-
tant questions regarding aortic aneurysm neck enlargement
in the thoracic aorta after endovascular repair. Whether the
incidence of neck enlargement and its potential association
with migration and endoleak is device dependent needs to
be explored in further studies.
Initial studies evaluating aneurysm neck morphology
after endovascular repair of infrarenal aortic aneurysms
(EVAR) also revealed aortic neck dilation.14-16 For in-
stance, early reports on the use of the EVT device (Endo-
vascular Technologies, Menlo Park, Calif) revealed pro-
gressive dilation of the proximal and distal aneurysm necks
over a 2-year period, but this neck expansion did not
correlate with any adverse events such as aneurysm expan-
sion, endoleak, or migration.14 While some early studies
corroborated these findings of neck dilation after EVAR,
others found no significant aortic neck dilation or early
dilation with a subsequent plateau of the neck diame-
ter.17-19
More recent follow-up studies on neck morphology
have supported the concept of early dilation with subse-
quent plateau. For instance, Sternbergh et al19 reported on
the influence of endograft oversizing on subsequent neck
dilation with use of the Zenith device (Cook, Blooming-
ton, Ind). This study revealed early dilation at 6 months,
which reached a plateau through 24 months, and these
investigators also found no correlation between neck ex-
pansion and adverse events. Similarly, May20 has reported
on long-term outcomes up to 11 years after EVAR from the
Sydney group that revealed early aortic neck dilation with a
subsequent plateau. Taken together, these studies suggest
early neck dilation after EVAR that is usually not associated
with adverse morphologic events such as migration and
endoleak.
Our study has several limitations that merit discussion:
First, despite the multicenter, prospective nature of this
study, there was a significant drop out at 3 years. This is
partially attributed to the high overall mortality rate in thiscohort of elderly patients with significant comorbidities (ie,
25% overall mortality at 2 years).7 Second, measurements
of graft migration were based on anatomic landmarks on
axial CT images, which can be inaccurate, especially with
changes in aortic conformation over time. Future studies
might use three-dimensional reconstruction and centerline
measurements for improved accuracy. Finally, a longer
follow-up is needed to assess whether neck dilation is
progressive and whether this would ultimately have an
effect on the rate of graft migration and subsequent en-
doleak.
CONCLUSION
Endovascular repair of descending thoracic aortic an-
eurysms has emerged as a viable alternative to open repair.
These core laboratory data on aortic neck morphology
from a multicenter trial demonstrate that both proximal
and distal mean aortic neck diameters increase during the
first 3 years after implantation. Significant neck dilation is
uncommon and is not associated with adverse events such
as graft migration or endoleak. Further surveillance of the
aortic neck over time is prudent.
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Dr Wesley Moore (Los Angeles, Calif). I have a question
concerning the methodology. Specifically, did you, as a group of
investigators, go to the core lab and actually repeat their measure-
ments, or did you depend upon the measurements that were
reported by the core lab consultants?
The reason I raise this question has to do with a personal
experience I had during the Ancure trial. When we had the
opportunity to compare personal core lab data with a recheck of
our own data, we found that the core lab was not infrequently
wrong, or they disagreed with their own measurements. If you
repeated these measurements yourself, I would be interested to
know what your inter- and intraobserver variability might be,
particularly when you are looking at tenths of a millimeter changes.
These variations may be fairly significant and perhaps the dilatation
you saw, even though minor, may not be as great as would appear
to be.
DrHassoun.All the measurements were done by members of
the core lab. They are performed in duplicate. And by definition,
the interobserver variability should be 15%. If not, it does go to
an adjudication panel composed of consultants who then decide on
the correct measurements.
Dr Peter Schubart (San Jose, Calif). In your study, did you
look at a possible correlation between graft oversizing and the
expansion that you saw?
Dr Hassoun. The simple answer is no. Certainly in the
infrarenal abdominal aorta graft, oversizing has been looked at.
And while it has been shown in some grafts to correlate with
migration, it does not necessarily correlate with gradual neck
dilation over time. We did not look at that specifically, and I think
that would be an excellent study.
The TAG device, by recommendations from the manufac-
turer, is oversized 7% to 18%, and it is not clear if any of the
aneurysms were oversized by greater than that and whether that
would lead to progressive neck dilation.
Dr Sean O’Neill (Cleveland, Ohio). Do you think that axial
CT scanning is an accurate method of assessing either migration or
true diameter in the tortuous thoracic aorta? Should you really be
using a centerline of flow analysis and taking your diameter mea-
surements perpendicular to that centerline of flow?
Dr Hassoun. I agree with you that centerline of flow mea-that most people are headed in terms of performing detailed length
measurements, et cetera. In the design of this study and in fact, the
trial, the measurements were performed with axial reconstructions.
In order tomaintain continuity during the study period, we did not
change our methodologies, and I think that would probably be the
wrong thing to do.
Dr John Chang (Roslyn, NY). As you indicate on your study,
the natural history shows that the aneurysm neck dilates as time
goes by. To prevent graft migration, would you consider, in your
future study, to do adjunctive measure, such as a minithoracotomy
or a thorascopic application of a cuff around your proximal and
distal fixation to prevent future migration?
Dr Hassoun. I believe you are asking whether we should
pursue adjunctive procedures for those patients who did have graft
migration. My answer to that would be that what we have seen is
that migration, based on how we measured it, did not correlate
with any adverse events. Therefore, I probably would not consider
such adjunctive procedures, but it certainly is something to keep in
mind.
Dr Jeffrey Ballard (Orange, Calif). Your life tables had a
significant patient drop-off between each period and no standard
errors were listed. Do you think your results would be different if
all the patients were followed through all those time periods?
DrHassoun. I think you ask a very important question and an
obvious one in terms of how I presented the data. There is
significant drop out of patients at 3 years (films that were not
received by the core lab) and for reasons other than just all-cause
mortality. So that certainly is going to affect the outcomes over
time, absolutely.
Dr Enrico Ascher (Brooklyn, NY). Were there any anatomic
parameters that you can help us with in terms of this subgroup of
aneurysms? The aortas that dilated, were the grafts placed closer to
the subclavian artery in these patients? Is there any anatomic hint?
Dr Hassoun. When we looked at achieved neck length (ie,
distance from PO to top of the graft), there was no correlation with
neck dilation. However, that is a little bit different than the actual
question, should we cover closer to the subclavian artery? I think
that is an analysis that we should do because it is an important
clinical question.
